Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03866382
Brief Title: Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

First Submitted : March 6, 2019
First Submitted that Met QC Criteria : March 6, 2019
First Posted : March 7, 2019

Last Update Submitted that Met QC Criteria : September 17, 2021
Last Update Posted : September 20, 2021